Ethic Inc’s Usana Health Sciences USNA Stock Holding History

Ethic Inc’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,234	Closed	-$287K	–	1302
2025 Q2	$287K	Buy	+9,234	New	+$262K	0.01%	995
2024 Q4	–	Sell	-5,427	Closed	-$263K	–	1225
2024 Q3	$263K	Buy	+5,427	New	+$223K	0.01%	921
2024 Q2	–	Sell	-5,427	Closed	-$263K	–	1175
2024 Q1	$263K	Buy	+5,427	New	+$266K	0.01%	917

Other funds holding USNA

SWGC

Summit Wealth Group (Colorado) Colorado Springs, Colorado $950M AUM 24.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ethic Inc's USNA Position: Q3 2025 in Review

Ethic Inc sold out of Usana Health Sciences (USNA) in Q3 2025, closing a stake of 9,234 shares — an estimated $287K sold.

Ethic Inc first reported a position in USNA in Q1 2024 and held it in 3 quarters. The position peaked at $287K in Q2 2025. 165 funds tracked by Wall St. Rank hold USNA as of Q3 2025.

Ethic Inc reported no remaining Usana Health Sciences position as of Q3 2025 after selling out during the quarter.
Ethic Inc sold 9,234 Usana Health Sciences shares in Q3 2025, an estimated $287K.
Ethic Inc first reported a position in Usana Health Sciences in Q1 2024 and held it in 3 quarters.
Ethic Inc's Usana Health Sciences position peaked at $287K in Q2 2025.
165 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2025.

Based on Ethic Inc's 13F filing for Q3 2025, filed 17 Oct 2025.